Fatigue Impacts Quality of Life in People with Spinocerebellar Ataxias. Lai RY, Rummey C, Amlang CJ, Lin CR, Chen TX, Perlman S, Wilmot G, Gomez CM, Schmahmann JD, Paulson H, Ying SH, Onyike CU, Zesiewicz TA, Bushara KO, Geschwind MD, Figueroa KP, Pulst SM, Subramony SH, Burns MR, Opal P, Duquette A, Ashizawa T, Hamedani AG, Davis MY, Srinivasan SR, Moore LR, Shakkottai VG, Rosenthal LS, Kuo SH Movement disorders clinical practice
Cognitive Deficits in Parkinson's Disease Are Associated with Neuronal Dysfunction and Not White Matter Lesions. Schröter N, Bormann T, Rijntjes M, Blazhenets G, Berti R, Sajonz BEA, Urbach H, Weiller C, Meyer PT, Rau A, Frings L Movement disorders clinical practice
[18F]PM-PBB3-PET Reveals Clinical and [18F]FDG-PET Mimics of 4-Repeat Tauopathy Caused by Creutzfeld-Jakob Disease. Schröter N, Blazhenets G, Meyer PT, Rijntjes M, Brumberg J Movement disorders clinical practice
Open-Label Phase 1 Futility Studies of Salsalate and Young Plasma in Progressive Supranuclear Palsy. VandeVrede L, Dale ML, Fields S, Frank M, Hare E, Heuer HW, Keith K, Koestler M, Ljubenkov PA, McDermott D, Ohanesian N, Richards J, Rojas JC, Thijssen EH, Walsh C, Wang P, Wolf A, Quinn JF, Tsai R, Boxer AL Movement disorders clinical practice
Disease-Modifying Treatments for Progressive Supranuclear Palsy. Stamelou M, Boxer AL Movement disorders clinical practice